|
DDX3X expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.12910000133115E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.95930000002065E-07 |
| Normal-vs-Stage2 |
2.14519999985896E-07 |
| Normal-vs-Stage3 |
1.57339999917738E-08 |
| Normal-vs-Stage4 |
6.54279963541171E-11 |
| Stage1-vs-Stage2 |
5.906400E-01 |
| Stage1-vs-Stage3 |
1.175640E-01 |
| Stage1-vs-Stage4 |
4.41869999999733E-05 |
| Stage2-vs-Stage3 |
4.835000E-01 |
| Stage2-vs-Stage4 |
5.462700E-03 |
| Stage3-vs-Stage4 |
2.181800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.3400999955322E-08 |
| Normal-vs-AfricanAmerican |
1.246850E-04 |
| Normal-vs-Asian |
3.46590000033231E-07 |
| Caucasian-vs-AfricanAmerican |
4.046400E-01 |
| Caucasian-vs-Asian |
9.302400E-01 |
| AfricanAmerican-vs-Asian |
4.289000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.02804439908277E-12 |
| Normal-vs-Female |
1.84729999996858E-06 |
| Male-vs-Female |
1.62447832963153E-12 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.0686999996643E-07 |
| Normal-vs-Age(41-60Yrs) |
4.01130000327043E-08 |
| Normal-vs-Age(61-80Yrs) |
2.72790001698553E-09 |
| Normal-vs-Age(81-100Yrs) |
6.261800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.871200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.980410E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.007600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.403440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.243400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.968000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.714400E-02 |
| Classical-VS-Follicular |
3.876600E-01 |
| Classical-VS-Other |
6.948000E-02 |
| Classical-VS-Normal |
2.62929999994554E-07 |
| Tall-VS-Follicular |
1.204620E-01 |
| Tall-VS-Other |
4.137400E-01 |
| Tall-VS-Normal |
3.23180004979662E-09 |
| Follicular-VS-Other |
2.075400E-01 |
| Follicular-VS-Normal |
1.57430000036207E-07 |
| Other-VS-Normal |
3.75790000006759E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.05319999890818E-08 |
| Normal-vs-N1 |
2.5389000013476E-08 |
| N0-vs-N1 |
4.493800E-01 |
|
|
